YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
* Glucotrack (GCTK [https://seekingalpha.com/symbol/GCTK]) announced [https://seekingalpha.com/pr/20663104-glucotrack-inc-announces-pricing-of-3-million-public-offering] on Thursday it priced a public offering of 0.17M common shares at $2.…
RUTHERFORD, N.J. & LA JOLLA, Calif., September 18, 2026--(BUSINESS WIRE)--Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), today announced that The University of Alabama's Culverhouse College of Business will continue…
RUTHERFORD, N.J., & LA JOLLA, Calif., September 02, 2026--(BUSINESS WIRE)--Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), today announced a collaboration with San Diego State University's (SDSU) Fowler College of Bu…
Medical research ©kaboompics.com Glucotrack (NASDAQ:GCTK) has regained compliance with Nasdaq's stockholders' equity requirement, with the Nasdaq Hearings Panel granting the company's request for continued listing subject to certain condit…
RUTHERFORD, N.J. & LA JOLLA, Calif., August 17, 2026--(BUSINESS WIRE)--Glucotrack, Inc. (Nasdaq: GCTK) today announced that the Nasdaq Hearings Panel has granted the Company's request for continued listing on The Nasdaq Stock Market, subje…
(RTTNews) - Today's top gainers included Glucotrack, whose subsidiary announced progress in the development strategy for LT-100, a novel non-narcotic therapy; Nuwellis, following expanded clinical recognition for its Aquadex therapy; Bausc…
(RTTNews) - This week, the healthcare sector saw multiple U.S FDA and European Commission approvals, strategic licensing and M&A activity, as well as pivotal clinical trial readouts and regulatory setbacks. Positive data readouts spanned m…
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), a leading investment banking and financial advisory firm, today announced that it served as exclusive financial advisor in the strategic business combination be…
RUTHERFORD, N.J. and SAN DIEGO, July 17, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), together with its operating business Lōkahi Therapeutics™ ("Lōkahi"), a clinical-stage biopharmaceutical com…
RUTHERFORD, N.J. and LA JOLLA, Calif., July 16, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) today announced the completion of its strategic business combination with Lōkahi Therapeutics, establishing a publicly listed, capital…
Medical research: syringe, bottles and mask ©Bicanski Glucotrack has completed its business combination with Lōkahi Therapeutics, transforming the company into a Lōkahi-controlled public platform focused on acquiring and advancing healthca…
By Karen Roman Glucotrack, Inc. (Nasdaq: GCTK) said the US Patent and Trademark Office issued a Notice of Allowance for a patent application which expands the intellectual property protecting the company's continuous blood glucose monitori…
Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring (CBGM) technology Company targeting U.S…
By Daniella Parra Glucotrack, Inc. (Nasdaq: GCTK) said it has submitted an Investigational Device Exemption application to the FDA to begin a U.S. clinical study for its fully implantable continuous blood glucose monitoring technology. The…
RUTHERFORD, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people wit…
By Karen Roman GlucoTrack, Inc. (Nasdaq: GCTK) said a peer-reviewed study published in the Institute of Electrical and Electronics Engineers Sensors Journal supported the feasibility of long-life implantable continuous glucose monitors lik…
(RTTNews) - Glucotrack, Inc. (GCTK), a medical technology company, reported financial results for the full year ended December 31, 2025, reflecting a narrower net loss. In addition, the firm provided a corporate update. Company profile Glu…
Company prepares to file Investigational Device Exemption (IDE) for Novel CBGM Technology, targeting US Clinical Trial Launch in Second Half of 2026 US Patent and Trademark Office (USPTO) issued patents for Glucotrack’s implantable continu…
* Glucotrack press release [https://seekingalpha.com/pr/20307323-glucotrack-reports-third-quarter-2025-financial-results-and-provides-update-on-recent] (GCTK [https://seekingalpha.com/symbol/GCTK]): Q3 GAAP EPS of -$4.64. * Research and de…
* GlucoTrack (NASDAQ:GCTK [https://seekingalpha.com/symbol/GCTK]) filed to sell 20.06 million common stock. * This prospectus is not an offer to sell these securities. * The company will not receive any proceeds from the sale of common sto…
Here are the top movers in Monday's session, showcasing the stocks with significant price changes. [topmovers] GAINERS TICKER CHANGE COMMENT ATCH [https://www.chartmill.com/stock/quote/ATCH/profile] 148.0% ATLASCLEAR HOLDINGS INC'S (NYSEAR…
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT ATCH [https://www.chartmil…
Let's delve into the US markets on Monday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. [gap] TOP GAP UP STOCKS TICKER CHANGE COMMENT NAOV [https://www.char…
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT GPUS [https://www.chartmill.com/stock/q…
After the closing bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. [postmarket] GAINERS TICKER CHANGE COMMENT CHEK [https://www.chartmill.com/stock/quote/CHEK/pro…
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session. [topmovers] GAINERS TICKER CHANGE COMMENT GCTK [https://www.char…
Intrigued by the market activity in the middle of the day on Friday? Uncover the key winners and losers of today's session in our insightful analysis. [topmovers] TOP GAINERS TICKER CHANGE COMMENT GCTK [https://www.chartmill.com/stock/quot…
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. [gap] GAP UP STOCKS TICKER CHANGE COMMENT OPI [https://www.chartmill.c…
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT GCTK [https://www…
US stock futures were little changed in Friday's premarket session ahead of consumer sentiment and o PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. [gap] TODAY'S GAP UP STOCKS TICKER CHANGE COMMENT CARM [https://www.c…
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT CARM [https://ww…
* Glucotrack press release [https://seekingalpha.com/pr/20201916-glucotrack-reports-second-quarter-2025-financial-results-and-recent-corporate-highlights] (NASDAQ:GCTK [https://seekingalpha.com/symbol/GCTK]): Q2 GAAP EPS of -$9.62. * Cash…
On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device Exemption submission to FDA of novel CBGM…
RUTHERFORD, N.J. - Glucotrack, Inc. (NASDAQ:GCTK), a medical device company currently trading at $5.83 and identified as undervalued by InvestingPro analysis, announced Wednesday that David S. Hirsh, MD, has joined the company as Medical D…
After the conclusion of the US market's regular session on Friday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. [postmarket] TODAY'S AFTER HOURS GAINERS TICKER CHANGE COMMENT PBM…